Kent W Neuenschwander

This inventor holds 27 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Rhone-Poulenc Rorer Pharmaceuticals Inc., Rorer Pharmaceutical Corporation, Aventis Pharmaceuticals Inc.. Active years: 1986-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kent W Neuenschwander. Retrieved from https://idiyas.com/inventor/kent-w-neuenschwander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 92.6

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 255(Granted Patents)

Location History:

Ambler, PA (US) (1986 - 1991)
Schwensville, PA (US) (2000)
Schwenksville, PA (US) (1995 - 2009)
Bridgewater, NJ (US) (2005 - 2012)

Company Filing History:

14 out of 111

Rhone-Poulenc Rorer Pharmaceuticals Inc.

patents

8 out of 109

Rorer Pharmaceutical Corporation

patents

2 out of 207

Aventis Pharmaceuticals Inc.

patents

4. 2 out of 146

William H. Rorer, Inc.

Years Active: 1986-2012

Loading Chart...

Areas of Expertise:

Antithrombotic Activity

Malonamide Derivatives

Squalene Synthase Inhibitors

HMG-COA Reductase Inhibitors

Chemical Compounds

Cycloalkyl Amine

Bicyclic Ethers

Aliphatic Amino Compounds

Substituted Cyclohexene

Multicyclic Tertiary Amine

Pharmaceutical Applications

Amino Bi- and Tri-carbocyclic

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8143242 - Malonamide derivatives with antithrombotic activity (2012-03-27),

2. 7612075 - Substituted oxoazaheterocyclyl compounds (2009-11-03),

3. 6977263 - Chemical compounds (2005-12-20),

4. 6057369 - Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) (2000-05-02),

5. 5596020 - Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase (1997-01-21),

6. 5561143 - Aliphatic amino bis-aryl squalene synthase inhibitors (1996-10-01),

7. 5534532 - Aliphatic amino bis-aryl squalene synthase inhibitors (1996-07-09),

8. 5494918 - Multicyclic tertiary amine polyaromatic squalene syntase inhibitors (1996-02-27),

9. 5455260 - Aliphatic amino bis-aryl squalene synthase inhibitors (1995-10-03),

10. 5451596 - Cycloalkyl amine bis-aryl squalene synthase inhibitors (1995-09-19),

11. 5395846 - Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase (1995-03-07),

12. 5385912 - Multicyclic tertiary amine polyaromatic squalene synthase inhibitors (1995-01-31),

13. 5001144 - Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors (1991-03-19),

14. 5001128 - HMG-COA reductase inhibitors (1991-03-19),

15. 4996234 - HMG-CoA reductase inhibitors (1991-02-26),

Title: Kent W Neuenschwander - Pioneering Inventor from Ambler, PA

Introduction: Kent W Neuenschwander is a renowned inventor hailing from Ambler, Pennsylvania. His innovative spirit and dedication to creating groundbreaking solutions have earned him a significant place in the world of patents and inventions.

Latest Patents: Kent W Neuenschwander holds several patents in various fields, showcasing his versatility and creativity in inventing new technologies to address modern challenges.

Career Highlights: Throughout his illustrious career, Kent W Neuenschwander has consistently pushed the boundaries of innovation. His contributions have not only revolutionized industries but have also improved the lives of many through his inventive solutions.

Collaborations: Kent W Neuenschwander has collaborated with leading companies, research institutions, and universities to bring his ideas to life. His ability to work with diverse teams and experts has led to the successful development and implementation of numerous patented inventions.

Conclusion: Kent W Neuenschwander's passion for innovation and his relentless drive to create have solidified his reputation as a pioneering inventor. His work continues to inspire future generations to think outside the box and pursue their inventive dreams.

Profile summary based on public USPTO records.